At a glance

ClinicalIndex Comparison Record

Phase 2Completed

Drug / intervention

Citalopram +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00073658

NCT00073658Phase 2Completed

Continuation Pharmacotherapy for Agitation of Dementia

University of Pittsburgh·interventional·Posted Dec 3, 2003·Updated Mar 10, 2014

In Brief

A Phase 2 clinical trial evaluating Citalopram and Risperidone for Dementia. Completed, across 1 site.

This study will compare the safety and effectiveness two medications, citalopram (Celexa®) and risperidone (Risperdal®).

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDementia

CountriesUnited States

Phase 2CompletedFinished

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJan 2000

First PostedDec 2003

Primary CompletionJun 2005

TodayJul 2026

First PostedDec 3, 2003

Enrollment StartJan 1, 2000

Primary CompletionJun 1, 2005

TodayJul 2, 2026

Enrollment to primary: 5.4 yearsPosted 22.6 years ago

Citalopramdrug

Risperidonedrug